Clare Ozawa

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Brandon Fenn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clare Ozawa:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 03 Jan 2023 Direct
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 03 Jan 2023 Indirect
Oyster Point Pharma, Inc. Director Stock Option (Right to Buy) 0 03 Jan 2023 Direct

Insider Reports Filed by Clare Ozawa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123001088-ozawa-clare-2023-01-03 Oyster Point Pharma, Inc. 03 Jan 2023 8 $0 4 Director 04 Jan 2023, 16:07
/report/000120919122035067-ozawa-clare-2022-06-06 Oyster Point Pharma, Inc. 06 Jun 2022 2 $0 4 Director 08 Jun 2022, 16:49
/report/000089924322001359-ozawa-clare-2022-01-05 Oyster Point Pharma, Inc. 05 Jan 2022 5 $0 4 Director, 10%+ Owner 07 Jan 2022, 15:18
/report/000089924321049597-ozawa-clare-2021-12-21 Oyster Point Pharma, Inc. 21 Dec 2021 5 $0 4 Director, 10%+ Owner 23 Dec 2021, 15:43
/report/000089924321040771-ozawa-clare-2021-10-18 Oyster Point Pharma, Inc. 18 Oct 2021 4 -$8,160,736 4 Director, 10%+ Owner 20 Oct 2021, 16:31
/report/000120919121039351-ozawa-clare-2021-06-07 Oyster Point Pharma, Inc. 07 Jun 2021 2 $0 4 Director 09 Jun 2021, 20:58
/report/000089924321019514-ozawa-clare-2021-05-12 Oyster Point Pharma, Inc. 12 May 2021 5 $0 4 Director, 10%+ Owner 14 May 2021, 16:44